An investor asked on the investor interaction platform: Dear secretary, is the app used by your company to test covid-19 in the United States the same as the app for chronic disease management in the United States? If not, can you consider merging into one app, which is more conducive to the company’s chronic disease management in the United States as soon as possible. What’s the current development status of your company’s chronic disease management in the United States.
Andon Health Co.Ltd(002432) (002432.SZ) said on the investor interaction platform in January 25th that the company’s diabetes diagnosis and treatment “O+O” new mode has cooperated with more than forty clinics in the United States.
